Literature DB >> 16461808

Effect of all-trans retinoic acid on tissue dynamics of choriocarcinoma cell lines: an organotypic model.

P M Chiu1, H C Feng, D M Benbrook, H Y S Ngan, U S Khoo, W C Xue, S W Tsao, K W Chan, A N Y Cheung.   

Abstract

BACKGROUND: All-trans retinoic acid (ATRA) is a natural vitamin A derivative that has a profound effect on the regulation of cell growth, differentiation and death. AIM: To investigate the tissue dynamic and cellular invasion effects of ATRA in choriocarcinoma (CCA), an aggressive trophoblastic tumour, by using a three-dimensional organotypic culture model system and cell invasion assay, respectively.
METHODS: An organotypic culture model of two CCA cell lines, JAR and JEG, was established. The effects of 1 microM ATRA on proliferation, differentiation and apoptosis on this CCA model were assessed by morphological assessment of the mitotic and apoptotic figures as well as by Ki-67 and caspase-related M30 cytoDeath antibody immunohistochemistry and the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labelling (TUNEL) assay. The effect of ATRA on p53 and its regulated protein product, WAF1/Cip1, was also evaluated with DO7 and p21(WAF1) antibodies, respectively. Moreover, the effect of ATRA on cellular (CCA) invasion was also investigated with Cell Invasion Kit on the JEG cell line.
RESULTS: ATRA was found to induce marked apoptosis in organotypic cultures of both cell lines, as evidenced by increased M30-positive cells (p<0.0001) and increased TUNEL-positive cells (p<0.0001) in treated cultures; to decrease proliferation, as evidenced by decreased Ki-67-positive cells (p<0.0001); and to decrease p53-DO7 immunoreactivity (p<0.0001) and increase p21(WAF1) (p<0.0001) immunoreactivity. 1.5 microM ATRA was found to effectively inhibit JEG cell invasion in the cell invasion assay.
CONCLUSION: ATRA treatment was found to inhibit invasion and proliferation and enhance apoptosis, probably by the activation of caspases and induction of differentiation. ATRA and synthetic retinoids may be alternative agents for the treatment of CCA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16461808      PMCID: PMC1860458          DOI: 10.1136/jcp.2005.025833

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  41 in total

1.  Immunohistochemical and mutational analysis of p53 tumor suppressor gene in gestational trophoblastic disease: correlation with mdm2, proliferation index, and clinicopathologic parameters.

Authors:  A. N. Y. Cheung; D. H. Shen; U. S. Khoo; M. P. M. Chiu; V. P. C. Tin; L. P. Chung; H. Y. S. Ngan
Journal:  Int J Gynecol Cancer       Date:  1999-03       Impact factor: 3.437

2.  Telomerase activity in gestational trophoblastic disease.

Authors:  A N Cheung; D K Zhang; Y Liu; H Y Ngan; D H Shen; S W Tsao
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

3.  Reduced expression of tissue inhibitor of metalloproteinase (TIMP)-2 in gestational trophoblastic diseases.

Authors:  Tomomitsu Okamoto; Rong Niu; Satoru Yamada; Masami Osawa
Journal:  Mol Hum Reprod       Date:  2002-04       Impact factor: 4.025

4.  Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression.

Authors:  S Y Wong; H Y Ngan; C C Chan; A N Cheung
Journal:  Mod Pathol       Date:  1999-11       Impact factor: 7.842

5.  Effects of all-trans retinoic acid on choriocarcinoma cells in vitro.

Authors:  S Yamada; T Okamoto; T Nakanishi; S Nomura; Y Tomoda
Journal:  J Obstet Gynaecol Res       Date:  1997-04       Impact factor: 1.730

6.  The significance of proliferating cell nuclear antigen in human trophoblastic disease: an immunohistochemical study.

Authors:  A N Cheung; H Y Ngan; W Z Chen; S L Loke; R J Collins
Journal:  Histopathology       Date:  1993-06       Impact factor: 5.087

7.  The expression of cathepsin D, oestrogen receptor and progestogen receptor in hydatidiform mole--an immunohistochemical study.

Authors:  A N Cheung; H Y Ngan; W F Ng; U S Khoo
Journal:  Histopathology       Date:  1995-10       Impact factor: 5.087

Review 8.  Retinoids in cancer therapy and chemoprevention: promise meets resistance.

Authors:  Sarah J Freemantle; Michael J Spinella; Ethan Dmitrovsky
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

9.  Induction of p21 (WAF-1/CIP1) during differentiation.

Authors:  R A Steinman; B Hoffman; A Iro; C Guillouf; D A Liebermann; M E el-Houseini
Journal:  Oncogene       Date:  1994-11       Impact factor: 9.867

Review 10.  Regulation of human extravillous trophoblast function by membrane-bound peptidases.

Authors:  Hiroshi Fujiwara; Toshihiro Higuchi; Yukiyasu Sato; Yoshihiro Nishioka; Bin-Xiang Zeng; Shinya Yoshioka; Keiji Tatsumi; Masamichi Ueda; Michiyuki Maeda
Journal:  Biochim Biophys Acta       Date:  2005-08-01
View more
  2 in total

1.  NF-kappaB regulation of endothelial cell function during LPS-induced toxemia and cancer.

Authors:  Tatiana Kisseleva; Li Song; Marina Vorontchikhina; Nikki Feirt; Jan Kitajewski; Christian Schindler
Journal:  J Clin Invest       Date:  2006-10-19       Impact factor: 14.808

2.  Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome.

Authors:  Michelle K Y Siu; Esther S Y Wong; Hoi Yan Chan; Hextan Y S Ngan; Kelvin Y K Chan; Annie N Y Cheung
Journal:  Am J Pathol       Date:  2008-09-04       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.